Browse hierarchy: [Cardiovascular (CV)](/submissions/CV) → [Subpart E — Cardiovascular Surgical Devices](/submissions/CV/subpart-e%E2%80%94cardiovascular-surgical-devices) → [21 CFR 870.4520](/submissions/CV/subpart-e%E2%80%94cardiovascular-surgical-devices/870.4520) → SHR — Device For Open Surgical Explant Of Endovascular Prostheses

# SHR · Device For Open Surgical Explant Of Endovascular Prostheses

_Cardiovascular · 21 CFR 870.4520 · Class 2_

**Canonical URL:** https://fda.innolitics.com/submissions/CV/subpart-e%E2%80%94cardiovascular-surgical-devices/SHR

## Overview

- **Product Code:** SHR
- **Device Name:** Device For Open Surgical Explant Of Endovascular Prostheses
- **Regulation:** [21 CFR 870.4520](/submissions/CV/subpart-e%E2%80%94cardiovascular-surgical-devices/870.4520)
- **Device Class:** 2
- **Review Panel:** [Cardiovascular](/submissions/CV)

## Identification

The XplantR Explant Tool is a non-implantable mechanical surgical tool indicated for use in open surgical conversion after endovascular abdominal aortic aneurysm repair to aid in the disengagement of the stent graft from the aorta. It is intended for use when, at the discretion of the operating physician, the proximal end of the endovascular graft is to be removed.

## Classification Rationale

FDA concludes that this device should be classified into Class II. FDA has determined that, for the previously stated indications for use, the XplantR can be classified in class II with the establishment of special controls for class II. FDA believes that class II (special) controls provide reasonable assurance of the safety and effectiveness of the device type.

## Recent Cleared Devices (1 of 1)

| Record | Device Name | Applicant | Decision Date | Decision |
| --- | --- | --- | --- | --- |
| [DEN250033](https://fda.innolitics.com/submissions/CV/subpart-e%E2%80%94cardiovascular-surgical-devices/SHR/DEN250033.md) | XplantR Explant Tool | Hjarta Care, LLC | Apr 17, 2026 | DENG |

## Top Applicants

- Hjarta Care, LLC — 1 clearance

---

**Source:** [https://fda.innolitics.com/submissions/CV/subpart-e%E2%80%94cardiovascular-surgical-devices/SHR](https://fda.innolitics.com/submissions/CV/subpart-e%E2%80%94cardiovascular-surgical-devices/SHR)

**Published by [Innolitics](https://innolitics.com)** — a medical-device software consultancy. We help companies design, build, and clear FDA-regulated software and AI/ML devices. If you're preparing [a 510(k)](https://innolitics.com/services/510ks/), [a De Novo](https://innolitics.com/services/regulatory/), [a SaMD](https://innolitics.com/services/end-to-end-samd/), [an AI/ML medical device](https://innolitics.com/services/medical-imaging-ai-development/), or [an FDA regulatory strategy](https://innolitics.com/services/regulatory/), [get in touch](https://innolitics.com/contact).

**Cite:** Innolitics at https://innolitics.com